PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 161 filers reported holding PROGENICS PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $336,000 | -65.8% | 56,543 | -60.9% | 0.02% | -68.8% |
| Q2 2017 | $983,000 | +503.1% | 144,743 | +666.2% | 0.06% | +540.0% |
| Q4 2016 | $163,000 | +196.4% | 18,890 | +44.2% | 0.01% | +233.3% |
| Q2 2016 | $55,000 | -96.8% | 13,100 | -96.6% | 0.00% | -97.2% |
| Q1 2016 | $1,693,000 | -36.5% | 388,300 | -10.7% | 0.11% | -16.9% |
| Q4 2015 | $2,665,000 | -2.5% | 434,723 | -9.0% | 0.13% | -3.0% |
| Q3 2015 | $2,733,000 | +16.7% | 477,824 | +52.3% | 0.13% | +48.9% |
| Q2 2015 | $2,341,000 | +110.9% | 313,790 | +69.1% | 0.09% | +104.5% |
| Q1 2015 | $1,110,000 | +254.6% | 185,591 | +348.5% | 0.04% | +100.0% |
| Q4 2014 | $313,000 | +189.8% | 41,377 | +98.2% | 0.02% | +266.7% |
| Q3 2014 | $108,000 | +163.4% | 20,880 | +107.1% | 0.01% | +100.0% |
| Q1 2014 | $41,000 | – | 10,080 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|